{
    "title": "Aurinia's lupus drug shows no new safety concerns",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4272922/Aurinias-lupus-drug-shows-no-new-safety-concerns.html",
    "date": "2017-03-01",
    "keywords": [
        "drug",
        "study",
        "voclosporin",
        "placebo",
        "company",
        "ln",
        "trial",
        "condition",
        "aurinia",
        "remission",
        "rate",
        "side",
        "approval",
        "grovermarch",
        "inc",
        "midstage",
        "safety",
        "developer",
        "pivotal",
        "yeartwo",
        "nephritis",
        "standardofcare",
        "therapyin",
        "weekson",
        "armln",
        "percent",
        "disorder",
        "bodys",
        "immune",
        "system",
        "protein",
        "tissue",
        "damage",
        "failure",
        "goal",
        "drugthe",
        "account",
        "mortality",
        "joseph",
        "note",
        "februaryon",
        "weekshowever",
        "malignancy",
        "addedin",
        "efficacy",
        "dose",
        "response",
        "versus",
        "showeda",
        "latestage",
        "food",
        "track",
        "status",
        "yearmore",
        "lupus",
        "pop",
        "singer",
        "selena",
        "gomezglaxosmithkline",
        "plc",
        "benlysta",
        "reporting",
        "grover",
        "bengaluru",
        "editing",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}